GWM
ARMP icon

Geneos Wealth Management’s Armata Pharmaceuticals ARMP Stock Holding History

Geneos Wealth Management’s Portfolio ARMP Stock Details ARMP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$942 Hold
92
– – ﹤0.01% 2414
2025
Q4 		$578 Buy
+92
New +$504 ﹤0.01% 2451
2020
Q4 		– Sell
-449
Closed -$1K – 2889
2020
Q3 		$1K Hold
449
– – ﹤0.01% 2485
2020
Q2 		$1K Hold
449
– – ﹤0.01% 2419
2020
Q1 		$1K Hold
449
– – ﹤0.01% 2334
2019
Q4 		$1K Hold
449
– – ﹤0.01% 2431
2019
Q3 		$1K Sell
449
-71
-14% -$279 ﹤0.01% 2361
2019
Q2 		$2K Buy
+520
New +$1.99K ﹤0.01% 2291

Other funds holding ARMP

MAM
Madison Asset Management Madison, Wisconsin $8.06B AUM 11.81% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Edgewood Management
Edgewood Management Greenwich, Connecticut $15.5B AUM 9.67% 1-Year Est. Return
DIG
Dauntless Investment Group Etna, New Hampshire $151M AUM 76.14% 1-Year Est. Return
SEI Investments
SEI Investments Oaks, Pennsylvania $108B AUM 26.14% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Geneos Wealth Management's ARMP Position: Q1 2026 in Review

Geneos Wealth Management held its Armata Pharmaceuticals (ARMP) position steady in Q1 2026 at 92 shares worth $942. The position accounts for ﹤0.01% of the portfolio, ranked #2414.

Geneos Wealth Management first reported a position in ARMP in Q2 2019 and has held it in 8 quarters since. The position peaked at $2K in Q2 2019. 45 funds tracked by Wall St. Rank hold ARMP as of Q1 2026.

  • Geneos Wealth Management held 92 shares of Armata Pharmaceuticals worth $942 as of Q1 2026.
  • Geneos Wealth Management left its Armata Pharmaceuticals share count unchanged in Q1 2026.
  • Armata Pharmaceuticals made up ﹤0.01% of Geneos Wealth Management's portfolio in Q1 2026, its #2414 holding.
  • Geneos Wealth Management first reported a position in Armata Pharmaceuticals in Q2 2019 and has held it in 8 quarters since.
  • Geneos Wealth Management's Armata Pharmaceuticals position peaked at $2K in Q2 2019.
  • 45 funds tracked by Wall St. Rank held Armata Pharmaceuticals as of Q1 2026.

Based on Geneos Wealth Management's 13F filing for Q1 2026, filed 5 May 2026.